The mechanism underlying central hypothyroidism induced by HIF-PH inhibitors has been elucidated as follows: roxadustat, owing to its structural similarity to T3, crosses the blood-brain barrier and interacts with the pituitary thyroid hormone receptor (THRβ) [3,4]. The gene discussed is THRB; the disease is Central hypothyroidism.